Ex-Filing Fees
Calculation of Filing Fee Table
Amendment No. 1 to
Schedule TO
CytoDyn Inc.
(Exact Name of Registrant as Specified in its Charter)
Transaction Valuation
| Transaction Valuation | Fee Rate | Amount of Filing Fee | ||||||||||
| Fee to Be Paid | $ | 35,662,840 | 0.0001476 | $ | 5,263.84 | (1) | ||||||
| Fees Previously Paid | $ | 4,662.33 | ||||||||||
| Total Transaction Valuation | $ | 35,662,840 | (1) | |||||||||
| Total Fees Due for Filing | $ | 5,263.84 | ||||||||||
| Total Fees Previously Paid | $ | 4,662.33 | ||||||||||
| Total Fee Offsets | ||||||||||||
| Net Fee Due | $ | 601.51 | ||||||||||
| (1) | Estimated for purposes of calculating the amount of the filing fee only. This transaction relates to an offer to amend and exercise warrants to purchase a maximum of 269,662,306 shares of common stock. The transaction value is calculated pursuant to Rule 0-11 under the Securities Exchange Act of 1934, as amended, as modified by Fee Rate Advisory No. 1 for the fiscal year 2024, using $0.13225 per share of common stock, which represents the average of the high and low sales prices of the common stock on June 17, 2024. |